. 2016 Sep 28;17(3):210–216. doi: 10.14744/AnatolJCardiol.2016.7174

Table 3.

Correlation of study parameters with each other and blood pressure

	T-SH R	AOPPs R	PCO R	IMA R	8-OHdG R	PAB R
Disease duration	-0.192	0.177	0.064	0.194	0.396^**	0.118
T-SH		-0.149	-0.297^*	-0.379^**	-0.410^**	-0.432^**
AOPPs	-0.149		0.194^*	0.314^*	0.411^**	0.141
PCO	-0.297^*	0.194^*		0.276^*	0.243^*	0.262^*
IMA	-0.379^**	0.314^*	0.276^*		0.396^**	0.338^**
8-OHdG	-0.410^**	0.411^**	0.243^*	0.396^**		0.372^**
PAB	-0.432^**	0.141	0.262^*	0.338^**	0.372^**
Office SBP	-0.630^**	0.297^*	0.293^*	0.430^**	0.422^**	0.509^**
Office DBP	-0.619^**	0.257^*	0.331^*	0.417^**	0.366^**	0.467^**
Average SBP^a	-0.478^**	0.384^**	0.269^*	0.418^**	0.510^**	0.610^**
Average DBP^a	-0.442^**	0.319^**	0.237^*	0.427^**	0.500^**	0.591^**
Daytime SBP^a	-0.511^**	0.406^**	0.245^*	0.425^**	0.544^**	0.609^**
Daytime DBP^a	-0.473^**	0.331^**	0.236^*	0.412^**	0.481^**	0.565^**
Nighttime SBP^a	-0.431^**	0.388^**	0.197^*	0.429^**	0.413^**	0.527^**
Nighttime DBP^a	-0.369^**	0.327^**	0.209^*	0.494^**	0.490^**	0.538^**

Pearson’s correlation was used for numerical data. Spearman’s correlation was used for nominal data. AOPPs - advanced oxidation protein products; BP - blood pressure; DBP - diastolic blood pressure; IMA - ischemia modified albumin; PAB - prooxidant-antioxidant balance; PCO - protein carbonyl; SBP - systolic blood pressure; T-SH - total thiol; WCH - white coat hypertension; 8-OHdG -8-hydroxy-2’-deoxyguanosine.

Ambulatory blood pressure monitoring.

P<0.05;

^**

P<0.001